Author: admin

https://www.sep.benfranklin.org/news/ben-franklin-healthcare-investments-1-3-million-in-four-companies/ Ben Franklin Healthcare Investments continues support of SFA Therapeutics with additional investment. The fund has invested in 4 companies in the southeast Pennsylvania region and continues to be the Philadelphia regions's "Partner with a Purpose" SFA Therapeutics is based in Jenkintown, Montgomery county.   Contacts: INVESTORS Mike Moyer LifeSci Advisors mmoyer@lifesciadvisors.com COMPANY Ira C. Spector, PhD CEO SFA Therapeutics, Inc. iraspector@sfatherapeutics.com   Source: SFA Therapeutics, Inc. ...

SFA-002 Updated Extension Data Showing 92% PASI 50 and 72% PASI 75 $4.5 Million Bridge Financing led by North South Ventures Composition of Matter patent which covers over 40 potential disease indications for SFA-002   JENKINTOWN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- SFA Therapeutics, a clinical-stage biotech using a first-in-class immuno-modulation technology platform, is pleased to announce the completion of a bridge financing of $4.5 million, led...

JENKINTOWN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) -- SFA Therapeutics, a clinical-stage biotech using a first-in-class immuno-modulation technology platform, announced positive results from their SFA-002 Phase 1b cohort 1 clinical trial. SFA’s oral pill SFA-002 has the potential to be disease-modifying, with durable responses and an excellent safety profile. SFA-002 simultaneously acts on multiple therapeutic pathways, unlike other drugs on the market which target a single...

Abstract Cancer is a multi-step process that can be viewed as a cellular and immunological shift away from homeostasis in response to selected infectious agents, mutations, diet, and environmental carcinogens. Homeostasis, which contributes importantly to the definition of “health,” is maintained, in part by the production of short-chain fatty acids (SCFAs), which are metabolites of specific gut bacteria. Alteration in the composition of gut bacteria, or...

READ MORE...